TeleSense RCM is a three-in-one device incorporating complete mobile cardiac telemetry (MCT), Holter and cellular event monitoring. It is ideal for cardiology practices and hospitals seeking to easily and more effectively manage symptomatic and asymptomatic cardiac event patients. With TeleSense, clinicians have the convenient flexibility to transition as needed among the three monitoring modes (MCT, Holter and event). The TeleSense features real-time streaming for live patient visibility, auto-detection of arrhythmia events and wireless transmission of three channels of ECG data, allowing clinicians to more accurately correlate patient symptoms to changes in electrical conduction of the heart. TeleSense can transmit up to 30 days of continuous ECG data across multiple cellular networks or utilizing a patient’s home or business WiFi network. Events are received and triaged through ScottCare’s highly-tested and proven receiving platform. TeleSense’s web-accessible reporting software then supports detailed and actionable reporting through daily heart rate trends; event reports; end-of-session reports; interim and summary statistics; and advanced administrative and clinical queries. Optional EHR integration enables reports to be easily viewed and e-signed by the physician prior to automated transmission to any HL7-based electronic health record (EHR) system. TeleSense also addresses the continuous concern of patient compliance. Not only is the device comfortable to wear, it is simple to set up and configure and it can even be configured remotely. Brightly-lit icons allow the patient to easily identify whether the device has sufficient power, whether leads are properly connected, if the device is recording, and the status of the WiFi or cellular connection. Patients can quickly record and immediately transmit self-identified events via a large, easily accessible button on the front of the device.
Read more

The next generation CE-marked Proxima bedside blood gas analyser (BGA) incorporates a new design and an extended analyte panel. Parameters now added to the new system include glucose and calculated parameters, such as P/F ratio and temperature corrected gases. The ability to monitor blood gases and measure blood glucose frequently and easily, directly by the patient, can enable earlier interventions and closer patient management, which is vital in fast changing critical situations. As a patient-dedicated system, Proxima is always connected to the patient via their arterial line and ready to go instantly. Since results are also delivered without the caregiver leaving the patient’s bedside, this significantly reduces time to result compared to conventional benchtop analysers. Its novel design means the system can travel with the patient on their pathway through the hospital. This is possible since the Proxima sensor contains an array of proven biosensor technology on a silicon chip, each a miniaturized version of the electrochemical sensors used in a traditional blood gas analyser. In addition to the sensor, the next generation Proxima system includes a medical grade tablet monitor with an intuitive touchscreen user interface. All results are reported to the monitor and seamlessly transferred directly into laboratory information systems and electronic patient records. This is a key requirement for the successful implementation of point-of-care (POC) testing.
As an ex-vivo analyser operating as a closed system, blood is drawn directly from the patient and over the Proxima sensor. Following analysis, all blood is returned to the patient, meaning that there is no blood loss and risk of iatrogenic anemia is reduced. Furthermore, infection risk to staff and patients is minimized as the arterial line remains closed throughout sampling. The design of Proxima also reduces pre-analytical errors due to the delivery of a high integrity blood sample direct to the sensor for immediate analysis with no mixing or anti-coagulant required. The addition of glucose to the new Proxima’s analyte panel is significant as glucose measurements play a key part in the care of critically ill patients. Both hyperglycemia and hypoglycemia are associated with increased morbidity and mortality in intensive care unit (ICU) patients. Keeping patients in normal glycemic range is difficult with current systems. The ability to regularly monitor arterial blood glucose using Proxima will support closer clinical management for improved glycemic control.
Read more

Dolphin FIS is a unique, patented technology that re-distributes pressure to prevent tissue damage by emulating the effects of a body ‘floating’ in a fluid medium. All Dolphin FIS surfaces provide an environment that promotes tissue perfusion and prevents injury related to compromised blood flow. Dolphin FIS has been proven clinically effective at speeding the healing of advanced stage or multiple pressure ulcers, flaps, skin grafts, burns and other wound conditions and is available for beds and seat cushions, providing protection for high risk patients throughout their hospital stay or at home.
Read more

Carestream will showcase its CARESTREAM Touch Prime and Touch Prime XE Ultrasound Systems at the 28th Euroson Congress of the EFSUMB taking place in Leipzig, Germany from 26 to 29 October. Both Touch Prime and Touch Prime XE systems provide exceptional image quality. They also streamline measurements to expedite clinician access to critical imaging information while boosting staff productivity. Advanced computing power and the company’s SynTek architecture deliver a simultaneous increase in frame rate, improved penetration and uniform focus throughout the field of view. Touch Prime and Touch Prime XE systems offer Smart Flow, Smart Flow Assist and Smart Select technology designed to further enhance workflow.
Smart Flow imaging technology eliminates the transducer angle limitations of ordinary Doppler ultrasound, and its proprietary Smart Flow method can visualize and measure velocity even when blood flow is perpendicular to the acoustic beam. The resulting measurements are angle independent-and therefore less prone to measurement error. The new ultrasound systems also visualize blood flow in all directions including axial and transverse, which provides more comprehensive information about hemodynamics to assist with diagnostic decisions. The benefits offered by this advanced ultrasound imaging technology can play a vital role in accurately assessing clinical applications such as evaluation of hemodialysis vascular access (AV fistulas and grafts) and quantification of complex flow patterns in the presence of stenosis. Colour coding and arrows automatically display information from Smart Flow technology on the Touch Prime Ultrasound platform. The length of the arrow, in addition to the colour, indicates magnitude. The orientation of the arrow indicates flow direction. Ordinary colour and spectral Doppler ultrasound only measure velocity of flow components toward or away from a transducer.
Smart Flow Assist automatically determines the highest area of flow, and places and adjusts sample size as well as angle corrections. This reduces the number of key strokes for velocity and volume measurements. Integrated one-touch transducer activation and a mode-programmable Smart Select button on the transducers allow a sonographer to reduce key strokes and improve productivity. A single touch of a button allows the user to activate the transducer as well as program two additional functions from a list of 16 commonly used functions.
Carestream’s advanced SynTek Architecture simultaneously provides enhanced spatial detail with increased frame rates for improved visualization of moving structures, while optimizing image formation to reduce noise and artifacts. Imaging and Doppler improvements allow for more consistent visualization of subtle tissue contrast differences and can increase the ability to see small structures. These systems also deliver uniform lateral resolution over the entire depth and deeper penetration for imaging of the abdomen and other areas.
Carestream offers specialized transducers for vascular imaging as well as radiology, OB/GYN and musculoskeletal imaging. A direct transducer interface to the ultrasound processing board delivers lower noise and higher image quality, and four transducers can be connected simultaneously to any of the system’s four ports.
The Touch Prime XE is capable of frame rates in excess of 100Hz while maintaining enhanced imaging detail, and includes optional features such as a DICOM package, barcode and RFID badge readers. Wireless connectivity provides rapid image transfers to PACS, RIS and other systems. An integrated gel warmer delivers added convenience and patient comfort.
The Touch Ultrasound platform’s design is based upon recommendations by sonographers and ultrasound professionals across the world. These systems have earned praise for a sealed, all-touch control panel that combines the speed and flexibility of a soft user interface with the tactile feedback of traditional keys. Etched marking for primary controls equips the user to easily locate frequently used functions without looking away from the image display monitor.
Read more